Company intelligence
Andel
Andel is a first-of-its-kind cooperative-buying platform that makes brand drugs more affordable.
About Andel
Andel is a cooperative digital marketplace that enables plan sponsors to provide affordable access to high-spend medications outside traditional pharmacy benefits, founded by Jay Bregman. Employees need these medications, but employers can’t afford to cover them. We solve this problem by leveraging the combined buying power of our members to go direct to manufacturers for better prices and a guaranteed supply. Then, employers add a subsidy of their choosing to further reduce costs to members. With true plug-and-play integration, it’s easy to get started at any point in the benefits cycle. Plus, our intuitive digital platform makes tracking costs and managing your benefit simple — while delivering a best-in-class pharmacy experience for members. The Andel Discount Drug Program is not insurance. The Andel Discount Drug Program offers reduced prices from participating providers, and discounts vary by provider and service. Participants are responsible for paying discounted charges, as the Andel Discount Drug Program does not make payments to providers on participants’ behalf. Discounts are available only from providers who have contracted to be in network. For more information and a list of participating providers, please contact us at support@andel.org, or by calling us at (833) 962 6335.
Verified activity
Signals from Andel
10 published signals
People
Andel hired Miguel Rosa to join Jay Bregman and the Andel team for this next chapter.
Reported by Miguel Rosa
People
Andel is hiring a Director of Member Success to reimagine how patients manage complex chronic conditions access and navigate their medications.
Reported by Maggie Gann, PMP
People
Andel hired Miguel Rosa as Chief Commercial Officer.
Reported by Jay Bregman
Presence & Recognition
Andel will be speaking at the Pharmacy Benefit Management Institute annual national conference in Orlando on the session titled Closing the Medication Access Gap: Employers, Manufacturers, and the Future of Coverage.
Reported by Jay Bregman
Research & Knowledge
Andel learned that Modena and Merck passed a major clinical trial for a personalized cancer vaccine for melanoma.
Reported by Jay Bregman
Presence & Recognition
Andel published a new video telling its own story and pushed it out alongside everything else it shipped this summer.
Reported by Jay Bregman
Presence & Recognition
Andel booked a rare stage for next week at PBMI's Annual National Conference on a panel with leaders from NFP, Merck, and MedImpact.
Reported by Jay Bregman
People
Andel signed a killer Chief Commercial Officer to date, starting September 1st.
Reported by Jay Bregman
Media
Andel picked up press coverage in Jewish News, Medical Economics, and Drug Topics.
Reported by Jay Bregman
Customers & Market
Andel closed two huge plan deals, one signed directly and one through a partner, both starting implementation now for January 1st launch.
Reported by Jay Bregman